. . . . . . . . . "rexulti is indicated for adjunctive treatment of major depressive disorder mdd see clinical studies 14 1 treatment of schizophrenia see clinical studies 14 2 rexulti is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder mdd 1 14 1 treatment of schizophrenia 1 14 2" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "Uu+l+iXcqzchYuvMiKFY12sV3nJ7wWPCX9vVrsP7+xc67SKix6x3lp7l7bkB58khWNATxErXqg5yDMkE07mrUqMrd5v7cjvJG6Js4JbzzApk37Yzn1z6daudrRxeFDmDzTnBgMqyZUIE0mrDAabm48KdIGhBn47XOEXYfc3fBkQ=" . . "2021-06-12T12:58:17.587+02:00"^^ . . . . .